Detalhe da pesquisa
1.
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
J Clin Oncol;
20(2): 476-84, 2002 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11786577